2021-01-05,Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M
2021-01-05,"Pharvaris Expands Board of Directors with Appointment of David Meeker, M.D., as Chair and Robert Glassman, M.D., as Director"
2020-12-22,Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
2020-12-11,"Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors"
2020-12-10,Is RYTM A Good Stock To Buy Now?
2020-12-02,"Biotech Stock Roundup: BIIB & SAGE Alliance, MRNA, BNTX Coronavirus Updates & More"
2020-11-30,Rhythm (RYTM) Up on FDA Approval of Weight Management Drug
2020-11-29,Rhythm Pharmaceuticals IMCIVREE Gets FDA Stamp of Approval; Stifel Boosts Price Target
2020-11-27,How This Small Biotech Is Targeting Obesity  And Why Shares Are Surging
2020-11-27,"Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency"
2020-11-04,Rhythm Pharmaceuticals Announces New Clinical Data on Setmelanotide at ObesityWeek® 2020
2020-11-02,Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
2020-10-30,Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology
2020-10-28,"Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America"
2020-10-20,We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth
2020-10-09,Rhythm Pharmaceuticals (RYTM) Looks Good: Stock Adds 5.1% in Session
2020-10-05,3 Strong Buy Healthcare Stocks With Major Catalysts Approaching
2020-09-14,"Rhythm Pharmaceuticals Appoints Yann Mazabraud as Executive Vice President, Head of International"
2020-09-09,Rhythm Pharmaceuticals to Present at Investor Conferences in September
2020-09-01,Rhythm (RYTM) Soars: Stock Adds 9.4% in Session
2020-08-06,Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
2020-08-03,Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
2020-07-27,Rhythm Pharmaceuticals Announces Appointment of Joseph Shulman as Senior Vice President of Technical Operations
2020-07-20,"Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer"
2020-07-16,"Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide in Bardet-Biedl Syndrome in Diabetes, Obesity and Metabolism"
2020-07-01,Rhythm Pharmaceuticals Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Setmelanotide for Treatment of POMC and LEPR Deficiency Obesities
2020-07-01,Rhythm Pharmaceuticals Announces Submission of Marketing Authorization Application to the European Medicines Agency for Setmelanotide in POMC and LEPR Deficiency Obesities
2020-06-26,"Hedge Funds Are Selling Rhythm Pharmaceuticals, Inc. (RYTM)"
2020-05-26,Rhythm Pharmaceuticals to Present Virtually at Upcoming Investor Conference in June
2020-05-13,Rhythm Pharmaceuticals Announces FDA Acceptance of New Drug Application for Setmelanotide for the Treatment of POMC and LEPR Deficiency Obesities
2020-05-05,Rhythm Pharmaceuticals to Present Virtually at 2020 BofA Securities Health Care Conference
2020-05-04,Rhythm Pharmaceuticals Reports First Quarter 2020 Financial Results
2020-04-21,We're Not Very Worried About Rhythm Pharmaceuticals's (NASDAQ:RYTM) Cash Burn Rate
2020-04-07,Rhythm Pharmaceuticals to Present Virtually at Needham & Co. 19th Annual Healthcare Conference
2020-03-30,Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations
2020-03-30,Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
2020-03-18,Rhythm Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for Setmelanotide for the Treatment of Alström Syndrome
2020-03-02,Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-25,Rhythm Pharmaceuticals to Present at Cowen & Co. 40th Annual Health Care Conference
2020-01-07,Rhythm Pharmaceuticals stock falls on news CEO is leaving
2020-01-07,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering"
2020-01-06,Rhythm Pharmaceuticals Announces Leadership Transition
2019-12-17,"Hedge Funds Are Dumping Rhythm Pharmaceuticals, Inc. (RYTM)"
2019-12-05,Rhythm Pharmaceuticals Completes Enrollment of Pivotal Cohort in Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
2019-11-22,Rhythm Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
2019-11-13,Rhythm Pharmaceuticals to Present at Stifel 2019 Healthcare Conference
2019-11-04,Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
2019-11-01,Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
2019-10-30,"Heres What Hedge Funds Think About Rhythm Pharmaceuticals, Inc. (RYTM)"
2019-10-30,Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ObesityWeek® 2019
2019-10-23,"Can We See Significant Institutional Ownership On The Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Share Register?"
2019-10-18,"Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares"
2019-10-16,"The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch"
2019-10-15,"Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering"
2019-10-15,"Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering"
2019-09-25,Rhythm Pharmaceuticals Provides Update on Research and Development Programs
2019-09-09,Rhythm Pharmaceuticals to Provide an Update on Genetic Sequencing Efforts and Expansion of Phase 2 Basket Study with Four Additional Rare MC4R Pathway-driven Disorders
2019-09-03,Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September
2019-08-07,Boston biotech Rhythm's stock jumps on success of drug for rare form of obesity
2019-08-07,Rhythm Rips Higher After Obesity Drug Aces Late-Stage Trials
2019-08-07,Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities
2019-08-06,"Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake"
2019-07-29,Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
2019-07-29,Rhythm Pharmaceuticals Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for Setmelanotide for the Treatment of Bardet-Biedl Syndrome
2019-07-24,Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
2019-07-17,Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity
2019-07-16,4 Strong Buy Biotechs With Big 3Q19 Catalysts
2019-06-19,Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors
2019-05-30,Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
2019-05-07,"Heres What Hedge Funds Think About Rhythm Pharmaceuticals, Inc. (RYTM)"
2019-05-07,Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference
2019-05-03,Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
2019-04-26,"If You Had Bought Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock A Year Ago, You Could Pocket A 10% Gain Today"
2019-04-02,Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference
2019-04-01,Medison to Nominate Six Highly Qualified Directors for Knight Therapeutics' Board to Strengthen Oversight and Drive Value Creation for All Shareholders
2019-03-28,Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
2019-03-08,Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
2019-03-04,Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference
2019-02-07,"Recent Analysis Shows Alexion Pharmaceuticals, Plug Power, Rayonier Advanced Materials, SunCoke Energy, Rhythm Pharmaceuticals, and Armstrong Flooring Market Influences  Renewed Outlook, Key Drivers of Growth"
2019-01-25,"A Look At The Fair Value Of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)"
2019-01-04,Rhythm Pharmaceuticals to Outline Expected 2019 Milestones and Review Updated Clinical Data in Bardet-Biedl Syndrome at 37th Annual J.P. Morgan Healthcare Conference
2018-12-13,Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
2018-12-06,"Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome"
2018-11-15,Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018
2018-11-09,Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
2018-11-07,Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference
2018-10-17,"Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals  New Horizons, Emerging Trends, and Upcoming Developments"
2018-10-15,"Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer"
2018-09-28,Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Bardet-Biedl Syndrome and Alström Syndrome at 57th Annual ESPE Meeting
2018-09-28,Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity
2018-09-25,Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference
2018-09-16,The Smartest People on Wall Street Are Buying These 3 Stocks. Should You Follow?
2018-09-07,Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference
2018-08-20,"New Research: Key Drivers of Growth for Harmonic, Astec Industries, Marlin Business Services, Arsanis, SunOpta, and Rhythm Pharmaceuticals  Factors of Influence, Major Initiatives and Sustained Production"
2018-08-08,Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
2018-07-23,Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
2018-06-25,"Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares"
2018-06-21,Here's Why Rhythm Pharmaceuticals Inc Rose as Much as 37% Today
2018-06-20,"Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering"
2018-06-18,"Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering"
